Project Grant R35GM161368
- Federal Grant Award Summary Northwestern University's Sponsored Research Division received a $440,000 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective August 1, 2025 through May 31, 2030. This Maximizing Investigators' Research Award (MIRA) supports fundamental research investigating how the epitranscriptome—the collection of chemical modifications on RNA molecules—regulates...
- Federal Grant Award Summary Northwestern University's Sponsored Research Division received a $540,000 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025 through August 31, 2030. This award supports high-throughput discovery and computational modeling of protein stability and dynamics, leveraging recent advances in machine learning to extend beyond protein structure...
- Federal Project Grant Award Summary Northwestern University's Sponsored Research Division received a $577,280 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective August 1, 2025, through May 31, 2030. The award supports fundamental research investigating the signaling and metabolic regulation of nucleotide metabolism and cell growth. The research program will elucidate molecular...
- Federal Project Grant Award Summary Northwestern University received a $107,838 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective July 15, 2025, with completion targeted for June 30, 2027. The award supports fundamental research aimed at reconstructing the ancestral gene regulatory network controlling neural crest and pluripotency stem cells in vertebrates. The research will...
- Federal Project Grant Award Summary Northwestern University received a $272,146 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective August 1, 2025 through July 31, 2030. The award supports fundamental research investigating the spatial and temporal organization of cellular functions at membrane contact sites (MCSs)—areas where distinct cellular membranes come into close physical...
- Summary of Federal Project Grant Award Northwestern University received a $1.76 million Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded August 12, 2025, with completion targeted for July 31, 2030. The award funds the establishment of the National Center for Translational and Developmental Proteomics (NCTDP), which will develop and disseminate advanced top-down mass spectrometry...
- Federal Project Grant Award Summary Northwestern University's Sponsored Research Division received a $118,559 Project Grant award from the National Institute of General Medical Sciences under the Biomedical Research and Research Training program (CFDA 93.859), effective August 1, 2025, through July 31, 2026. The award supports fundamental biomedical research investigating metalloenzyme-guided discovery of novel ribosomally synthesized, post-translationally modified peptide (RIPP) natural...
- Federal Project Grant Award Summary Northwestern University received a $150,104 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective March 12, 2026 through November 30, 2028. This award funds research to map the sequence-function landscape of SpyCatcher, a small reactive protein consisting of 80 amino acid residues that forms covalent bonds with its substrate SpyTag. The research...
- Federal Grant Award Summary The University of Chicago received a $196,460 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded on May 15, 2025, with completion targeted for June 30, 2028. This award funds research to determine the role of HOTTIP (long non-coding RNA) in the regulation of the HOXA gene cluster. The project delivers a novel molecular engineering technology platform...
- Federal Grant Award Summary Northwestern University's Sponsored Research Division received a $457,112 Project Grant from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866) for the period January 1, 2026 through December 31, 2030. The research investigates Death Induced by Survival Elimination (DISE), a cellular death mechanism involving short RNAs (sRNAs) that target genes critical for cell survival. The project will advance understanding of how DISE functions...
Northwestern University received a $440,000 Project Grant award from the National Institute of General Medical Sciences under the Biomedical Research and Research Training program (CFDA 93.859), effective March 12, 2026 through February 28, 2031. The award supports fundamental research investigating the regulatory roles of noncoding ribonucleic acids (ncRNAs), specifically a newly identified class called downstream-of-gene (DOG) RNAs, in gene expression and cellular stress responses. The research deliverables encompass investigation of the molecular mechanisms underlying DOG RNA biogenesis, processing, and function in transcriptional stress responses and cellular homeostasis. Using advanced genomic, biochemical, and computational methodologies including PRO-Seq (Precision Run-On sequencing), RNA-Seq, and ChIP-Seq (Chromatin Immunoprecipitation sequencing), the project will elucidate how DOG RNAs regulate chromatin accessibility, transcriptional dynamics, and three-dimensional genome organization. The anticipated research outcomes include novel insights into ncRNA-mediated gene regulation mechanisms and identification of potential therapeutic targets for restoring transcriptional homeostasis in diseases such as cancer where transcriptional dysregulation is central to pathogenesis. The research will be conducted at Northwestern University's Chicago, Illinois facility.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $440.0k | 3/10/26 |